The Difference Between Denisumab and Zolodronic Acid in Myeloma

So, you've had a real leadership role over the years in management of bone disease in myeloma. We don't talk about this that much, but still so relevant. This is a great review article that you did. I really recommend for people to check out or reviewing the whole issue of bone disease. One of the big issues here is the difference between Denisumab and Zolodronic acid. You want to comment on how you view the microenvironment and how that ties into what you see clinically.